As soon as it can be injected in to the muscles, the nerve alerts that tell the muscles to deal are blocked. As a result, the muscles develop into temporarily paralyzed or weakened. On August two, 2010, the US FDA declared the acceptance of incobotulinumtoxinA (Xeomin®) for the treatment